Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-10-18

FDA Approved: IXEMPRA — Supplemental Application (R-Pharm US Operating, LLC)

View source ↗

Summary

The FDA approved a supplemental application for IXEMPRA (ixabepilone) submitted by R-Pharm US Operating, LLC, indicating an updated labeling/indication for the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ixempra (ixabepilone)

Snippet

SUPPL AP for IXEMPRA (IXABEPILONE)